SEARCH

SEARCH BY CITATION

References

  • Colquhoun, D. (1971). Lectures on Biostatistics. Oxford : Oxford University Press.
  • Compton, D. R., Aceto, M. D., Lowe, J. & Martin, B. R. (1996). In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of Δ9-tetrahydrocannabinol-in-duced responses and apparent agonist activity. J. Pharmacol. Exp. Ther., 277, 586594.
  • Coutts, A. A., Fernando, S. R., Griffin, G., Nash, J. E. & Pertwee, R. G. (1995). Evidence that guinea-pig small intestine contains CB1 cannabinoid receptors and possibly also a cannabinoid receptor ligand. Br. J. Pharmacol. (Proc. suppl.), 116, 46P.
  • Cowie, A. L., Kosterlitz, H. W. & Watt, A. J. (1968). Mode of action of morphine-like drugs on autonomic neuro-effectors. Nature, 220, 10401042.
  • Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 19461949.
  • Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L. & Mitchell, R. L. (1995). Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol., 48, 443450.
  • Gifford, A. N. & Ashby, C. R. (1996). Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J. Pharmacol. Exp. Ther., 277, 14311436.
  • Gill, E. W., Paton, W. D. M. & Pertwee, R. G. (1970). Preliminary experiments on the chemistry and pharmacology of cannabis. Nature, 228, 134136.
  • Greenberg, R., Kosterlitz, H. W. & Waterfield, A. A. (1970). The effects of hexamethonium, morphine and adrenaline on the output of acetylcholine from the myenteric plexus-longitudinal muscle preparation of the ileum. Br. J. Pharmacol. Proc. Suppl., 40, 553P.
  • Herkenham, M. (1995). Localization of cannabinoid receptors in brain and periphery. In Cannabinoid Receptors, ed. Pertwee, R. G. pp. 145166, London : Academic Press.
  • Ishac, E. J. N., Jiang, L., Lake, K. D., Varga, K., Abood, M. E. & Kunos, G. (1996). Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol., 118, 20232028.
  • Kilbinger, H. (1977). Modulation by oxotremorine and atropine of acetylcholine release evoked by electrical stimulation of the myenteric plexus of the guinea-pig ileum. Naunyn-Schmiedeberg's Arch. Pharmacol., 300, 145151.
  • Layman, J. M. & Milton, A. S. (1971). Some actions of Δ9-tetrahydrocannabinol and cannabidiol at cholinergic junctions. Br. J. Pharmacol. Proc. Suppl., 41, 379P.
  • Leff, P. (1995). The two-state model of receptor activation. Trends Pharmacol. Sci., 16, 8997.
  • Lord, J. A. H., Waterfield, A. A., Hughes, J. & Kosterlitz, H. W. (1977). Endogenous opioid peptides: multiple agonists and receptors. Nature, 267, 495499.
  • Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminiski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., Pertwee, R. G., Griffin, G., Bayewitch, M., Barg, J. & Vogel, Z. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 8390.
  • North, R. A. & Nishi, S. (1974). Properties of the ganglion cells of the myenteric plexus of the guinea-pig ileum determined by intracellular recording. In Proc. Fourth. Int. Symp. Gastrointestinal motility. ed. Daniel, E. E. pp. 667676, Vancouver : Mitchell Press.
  • Paton, W. D. M., Pertwee, R. G. & Temple, D. (1972). The general pharmacology of cannabinoids. In Cannabis and Its Derivatives, ed. Paton, W. D. M. & Crown, J. pp. 5075, Oxford : Oxford University Press.
  • Paton, W. D. M. & Zar, M. A. (1968). The origin of acetylcholine released from the guinea-pig intestine and longitudinal muscle fibres. J. Physiol., 194, 1333.
  • Pertwee, R. G. & Fernando, S. R. (1996). Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br. J. Pharmacol., 118, 20532058.
  • Pertwee, R. G., Fernando, S. R., Griffin, G., Ryan, W. J., Razdan, R. K. & Martin, B. R. (1996a). Agonist-antagonist characterization of 6′-cyanohex-2′-yne-Δ9-tetrahydrocannabinol in two isolated tissue preparations. Eur. J. Pharmacol., 315, 195201.
  • Pertwee, R. G., Fernando, S. R., Nash, J. E. & Coutts, A. A. (1996b). Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 21992205.
  • Pertwee, R. G., Stevenson, L. A., Elrick, D. B., Mechoulam, R. & Corbett, A. D. (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol., 105, 980984.
  • Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J.-C. & Le Fur, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240244.
  • Roth, S. H. (1978). Stereospecific presynaptic inhibitory effect of delta-9-tetrahydrocannabinol on cholinergic transmission in the myenteric plexus of the guinea-pig. Can. J. Physiol. Pharmacol., 56, 968975.
  • Santucci, V., Storme, J.-J., Soubrie, P. & Le Fur, G. (1996). Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci., 58, PL103PL110.
  • Schlicker, E., Timm, J. & Göthert, M. (1996). Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 791795.
  • Showalter, V. M., Compton, D. R., Martin, B. R. & Abood, M. E. (1996). Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther., 278, 989999.
  • Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A. & Waku, K. (1995). 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun., 215, 8997.
  • Tallarida, R. J., Cowan, A. & Adler, A. W. (1979). pA2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci., 25, 637654.
  • Ten Berge, R. E. J., Weening, E. C., Roffel, A. F. & Zaagsma, J. (1996). Differences in the prejunctional effects of methacholine and pilocarpine on the release of endogenous acetylcholine from guinea-pig trachea. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 606611.
  • Tersigni, T. J. & Rosenberg, H. C. (1996). Local pressure application of cannabinoid agonists increases spontaneous activity of rat substantia nigra pars reticulata neurons without affecting response to iontophoretically-applied GABA. Brain Res., 733, 184192.
  • Waterfield, A. A. (1973). Factors Affecting Acetylcholine Release from the Myenteric Plexus of the Ileum. Ph.D. Thesis. University of Aberdeen.